牛牛AI助理已提取核心訊息
Intuitive Surgical, Inc. (Intuitive) released unaudited preliminary financial results for the fourth quarter and full year of 2023 on January 9, 2024. The report highlighted a 21% growth in worldwide da Vinci procedures in Q4 2023 compared to Q4 2022, and a 22% increase for the full year. The company placed 415 da Vinci surgical systems in Q4, marking a 12% increase from the previous year, and 1,370 systems in 2023, up by 8% from 2022. Revenue for Q4 2023 is estimated at approximately $1.93 billion, a 17% rise from Q4 2022, with full-year revenue expected to be around $7.12 billion, representing a 14% increase. The growth in procedures and revenue was attributed to the adoption of the company's platforms and increased procedure volumes, particularly in U.S. general surgery and international cancer procedures. The report also noted a recovery in procedure...Show More
Intuitive Surgical, Inc. (Intuitive) released unaudited preliminary financial results for the fourth quarter and full year of 2023 on January 9, 2024. The report highlighted a 21% growth in worldwide da Vinci procedures in Q4 2023 compared to Q4 2022, and a 22% increase for the full year. The company placed 415 da Vinci surgical systems in Q4, marking a 12% increase from the previous year, and 1,370 systems in 2023, up by 8% from 2022. Revenue for Q4 2023 is estimated at approximately $1.93 billion, a 17% rise from Q4 2022, with full-year revenue expected to be around $7.12 billion, representing a 14% increase. The growth in procedures and revenue was attributed to the adoption of the company's platforms and increased procedure volumes, particularly in U.S. general surgery and international cancer procedures. The report also noted a recovery in procedure volumes following early 2023 COVID-19 resurgences in China. Intuitive's CEO, Gary Guthart, expressed satisfaction with the platform adoption and the company's focus on supporting customers' pursuit of the quadruple aim in acute interventions. The full financial results will be discussed in more detail during a conference call on January 23, 2024, following the company's presentation at the J.P. Morgan Healthcare Conference on January 10, 2024.
Intuitive Surgical, Inc.（Intuitive）於2024年1月9日發佈了2023年第四季度和全年未經審計的初步財務業績。該報告強調，與2022年第四季度相比，全球達芬奇手術在2023年第四季度增長了21％，全年增長了22％。該公司在第四季度安裝了415套達芬奇手術系統，比上年增長了12％；在2023年安裝了1,370套系統，比2022年增長了8％。2023年第四季度的收入估計約爲19.3億美元，較2022年第四季度增長17％，全年收入預計約爲71.2億美元，增長14％。手術和收入的增長歸因於公司平台的採用和手術量的增加，尤其是在美國普通外科和國際癌症手術中。該報告還指出...展開全部
Intuitive Surgical, Inc.（Intuitive）於2024年1月9日發佈了2023年第四季度和全年未經審計的初步財務業績。該報告強調，與2022年第四季度相比，全球達芬奇手術在2023年第四季度增長了21％，全年增長了22％。該公司在第四季度安裝了415套達芬奇手術系統，比上年增長了12％；在2023年安裝了1,370套系統，比2022年增長了8％。2023年第四季度的收入估計約爲19.3億美元，較2022年第四季度增長17％，全年收入預計約爲71.2億美元，增長14％。手術和收入的增長歸因於公司平台的採用和手術量的增加，尤其是在美國普通外科和國際癌症手術中。該報告還指出，在 2023 年初 COVID-19 在中國捲土重來之後，手術量有所回升。Intuitive的首席執行官Gary Guthart對該平台的採用以及公司專注於支持客戶在急性干預中實現四重目標表示滿意。繼公司於2024年1月10日在摩根大通醫療保健會議上發表演講之後，將在2024年1月23日的電話會議上更詳細地討論完整的財務業績。
有用
沒用